HOME >> BIOLOGY >> NEWS
Lizard research bolsters theory that forest edges are hotbeds of speciation

ving organisms, but also may be important to forming new species.

Schneider, who is a principal investigator for CTR, says: "When we think about the processes that generate biodiversity in rainforests, we need to move beyond the traditional view of geographic isolation and focus on the ecological opportunities that are provided by habitat gradients and newly formed habitats."

In their study, the researchers found that open-forest lizards were smaller, had shorter limbs and a bigger head, and became sexually mature earlier than their rainforest counterparts.

To test for the selective forces influencing the rapid changes in the skinks' appearance and reproductive maturity, the researchers looked at predation. Because theoretical studies suggest that natural selection caused by predation favors the evolution of smaller bodies and earlier reproduction, they suspected that lizard-eating birds hunting in open forests were the agents of natural selection.

The researchers placed 480 plastic lizard decoys, painted to match the striped, reddish skink, throughout the dense rainforest and the open dry forest. By looking for the telltale bite marks created by bird bills, the researchers identified how many models were attacked.

According to Schneider, it was no contest between the two sites. Twenty-one models were targeted in the open, transitional forest, versus only four in the closed rainforest habitat.

"We have identified a potential selective mechanism that would explain the difference in size between rainforest and open forest habitats," says Schneider. "The changes in morphology across habitats, in spite of high levels of gene flow, suggest rapid adaptive evolution in response to natural selection."

The evolutionary mechanisms that have fostered the rich tapestry of plant and animal species found in tropical rainforests, which harbor roughly half the Earth's species, have been hotly debated for decades.
'"/>

Contact: Merrik Bush-Pirkle
merrik@sfsu.edu
415-338-6747
San Francisco State University
21-Nov-1999


Page: 1 2 3 4

Related biology news :

1. Lizards and salamanders may use lungs to hear, study says
2. Lizards do really learn to recognize people
3. Caribbean Lizards Evolve Independently
4. Leader in cancer treatment and prevention research honored
5. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
6. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
7. Belgian researchers explore revolutionary approach to angiogenesis
8. Award winning researchers reveal potential new role for Glivec
9. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
10. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
11. Gene chips research in cotton could lead to superior variety

Post Your Comments:
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... in Europe and the United States and plenary talks ... planned for SPIE Optics + Optoelectronics next ... over 700 technical presentations in 17 conferences alongside a ... for optics and photonics , the event will run ...
(Date:3/30/2015)... 30, 2015  Naldemedine, an investigational peripherally acting ... & Co., Ltd., met its primary and secondary ... for the treatment of opioid-induced constipation (OIC) in ... therapy. Study results showed that naldemedine (0.2 mg ... frequency of spontaneous bowel movement (SBM) compared with ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: